Literature DB >> 16955839

Passive transfer of naturally acquired specific immunity against West Nile Virus to foals in a semi-feral pony herd.

Pamela A Wilkins1, Amy L Glaser, Sue M McDonnell.   

Abstract

Horses naturally exposed to West Nile Virus (WNV) or vaccinated against WNV develop humoral immunity thought to be protective against development of clinical disease in exposed or infected animals. No reports evaluate the efficacy of passive transfer of naturally acquired specific WNV humoral immunity from dam to foal. The purpose of this study was to investigate passive transfer of naturally acquired immunity to WNV to foals born in a herd of semi-feral ponies, not vaccinated against WNV, in an endemic area, with many dams having seroconverted because of natural exposure. Microwell serum neutralization titers against WNV were determined in all mares and foals. Serum IgG concentration was determined in foals by serial radial immunodiffusion. Differences in IgG concentration between seropositive and seronegative foals were examined by means of the Mann-Whitney U-test. Linear regression was used to evaluate the association between mare and foal titers. Seventeen mare-foal pairs were studied; 1 foal had inadequate IgG concentration. IgG concentration was not different between seronegative and seropositive foals (P = .24). Mare and foal titers were significantly correlated in foals with adequate passive transfer of immunity (Spearman's rho = .84; P < .001); >90% of the foal's titer was explained by the mare's titer (R2 = 0.91; P < .001). Passive transfer of specific immunity to WNV is present in pony foals with adequate passive transfer of immunity born to seroconverted mares.

Entities:  

Mesh:

Year:  2006        PMID: 16955839     DOI: 10.1892/0891-6640(2006)20[1045:ptonas]2.0.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  6 in total

1.  Seroprevalence of West Nile virus in feral horses on Sheldon National Wildlife Refuge, Nevada, United States.

Authors:  J Christian Franson; Erik K Hofmeister; Gail H Collins; Robert J Dusek
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

2.  Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals.

Authors:  Helle Bielefeldt-Ohmann; Natalie A Prow; Wenqi Wang; Cindy S E Tan; Mitchell Coyle; Alysha Douma; Jody Hobson-Peters; Lisa Kidd; Roy A Hall; Nikolai Petrovsky
Journal:  Vet Res       Date:  2014-12-17       Impact factor: 3.683

Review 3.  The Immune Responses of the Animal Hosts of West Nile Virus: A Comparison of Insects, Birds, and Mammals.

Authors:  Laura R H Ahlers; Alan G Goodman
Journal:  Front Cell Infect Microbiol       Date:  2018-04-03       Impact factor: 5.293

4.  One Health approach for West Nile virus surveillance in the European Union: relevance of equine data for blood safety.

Authors:  Johanna J Young; Denis Coulombier; Dragoslav Domanović; Hervé Zeller; Céline M Gossner
Journal:  Euro Surveill       Date:  2019-04

Review 5.  Passive immunisation, an old idea revisited: Basic principles and application to modern animal production systems.

Authors:  Chris J Hedegaard; Peter M H Heegaard
Journal:  Vet Immunol Immunopathol       Date:  2016-04-26       Impact factor: 2.046

Review 6.  Equids' Core Vaccines Guidelines in North America: Considerations and Prospective.

Authors:  Hélène Desanti-Consoli; Juliette Bouillon; Ronan J J Chapuis
Journal:  Vaccines (Basel)       Date:  2022-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.